The suitability of micronuclei as markers of relative biological effect. (2022)
Attributed to:
BioProton: Biologically relevant dose for Proton Therapy Planning
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/mutage/geac001
PubMed Identifier: 35137176
Publication URI: http://europepmc.org/abstract/MED/35137176
Type: Journal Article/Review
Volume: 37
Parent Publication: Mutagenesis
Issue: 1
ISSN: 0267-8357